OBJECTIVE:

To determine 5-year survival (global and disease-free) and its relationship

with variables: recurrence, clinical stage, histological type and grade, tumoral size, axillary lymph node invasion and immunohistochemistry.

MATERIALS AND METHODS:

Observational, descriptive and retrospective study carried out in patients with breast cancer attended in 2010 at the Hospital Militar de la Mujer, in Mexico City, confirmed by histopathology. The overall survival and disease-free to five years has been established from the time elapsed since the diagnosis until the occurrence of an event (recurrence, metastasis or death) or date of the last contact, with a limit of December 2015.

RESULTS:

197 records were analysed; however 78 were discarded either: by repetition of cases (49), due to lack of information (21) and due to recurrences from previous years (8). The age range were 30 and 84 years, with an average of 56.2 years. The cases in early stage (CS IIA) was 40%, and overall survival 81% at 5 years. In the patients with recurrences the probabilities of survival were 51%; and the patients in advanced stages were less likely to survive. It was not possible demonstrate of statistically significant association between tumoral size, type and histological grade, immunohistochemistry and lymph node invasion and survival.

CONCLUSIONS:

The study shows that patients in the update stages have less likely to survive, so it is imperative that efforts continue in health promotion until getting the detection in curable stages.